Select country change
Shopping cart (0 , 0,00 ) Menu Search
Distributed product

ADMA ELISA, High Sensitivity

  • Regulatory status:RUO
  • Type:Competitive ELISA, Immobilized antigen
  • Other names:Asymmetric Dimethylarginine
Please select your region to see available products and prices.
Cat. No. Size Price


REA209/96R 96 wells (1 kit)
PubMed Product Details
Technical Data

Type

Competitive ELISA, Immobilized antigen

Applications

Serum, Plasma-EDTA, Plasma-Heparin, Cell culture medium

Sample Requirements

20-25 µl/well

Shipping

At ambient temperature. Upon receipt, store the product at the temperature recommended below.

Storage/Expiration

Store the complete kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Calibration Curve

Calibration Range

0,1-5 µmol/l

Limit of Detection

0.01 µmol/l

Intra-assay (Within-Run)

8,3 %

Spiking Recovery

92-104 %

Dilutation Linearity

94-110 %

Summary

Research topic

Blood pressure regulation and NO metabolism, Cardiovascular disease

Summary

The vascular endothelium plays a central role in the regulation of vascular structure and function, mainly due to the formation of endothelium-derived nitric oxide (NO). NO is formed by the enzyme NO synthetase (NOS) from the amino acid precursor L-arginine. NOS activity can be downregulated by ADMA, an endogenous inhibitor of NOS. Elevated ADMA levels in plasma have been found in clinical studies including patients with hypercholeste­rolemia, hypertension, chronic heart failure, chronic renal failure and other internal disorders. ADMA may have diagnostic relevance as a novel cardiovascular risk marker.

Product References (14)

References

  • Antoniades C, Tousoulis D, Marinou K, Vasiliadou C, Tentolouris C, Bouras G,Pitsavos C, Stefanadis C. Asymmetrical dimethylarginine regulates endothelialfunction in methionine-induced but not in chronic homocystinemia in humans:effect of oxidative stress and proinflammatory cytokines. Am J Clin Nutr. 2006Oct;84(4):781-8. PubMed PMID: 17023704. See more on PubMed
  • Charitidou C, Farmakiotis D, Zournatzi V, Pidonia I, Pegiou T, Karamanis N,Hatzistilianou M, Katsikis I, Panidis D. The administration of estrogens,combined with anti-androgens, has beneficial effects on the hormonal features andasymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.Atherosclerosis. 2008 Feb;196(2):958-65. Epub 2007 Apr 6. PubMed PMID: 17418849. See more on PubMed
  • Horowitz JD, Heresztyn T. An overview of plasma concentrations of asymmetricdimethylarginine (ADMA) in health and disease and in clinical studies:methodological considerations. J Chromatogr B Analyt Technol Biomed Life Sci.2007 May 15;851(1-2):42-50. Epub 2006 Oct 11. Review. PubMed PMID: 17045556. See more on PubMed
  • Iribarren C, Husson G, Sydow K, Wang BY, Sidney S, Cooke JP. Asymmetricdimethyl-arginine and coronary artery calcification in young adults enteringmiddle age: the CARDIA Study. Eur J Cardiovasc Prev Rehabil. 2007Apr;14(2):222-9. PubMed PMID: 17446800. See more on PubMed
  • Konishi H, Sydow K, Cooke JP. Dimethylarginine dimethylaminohydrolase promotesendothelial repair after vascular injury. J Am Coll Cardiol. 2007 Mar13;49(10):1099-105. Epub 2007 Feb 23. PubMed PMID: 17349891. See more on PubMed
  • Korish AA, Arafah MM. Catechin combined with vitamins C and E amelioratesinsulin resistance (IR) and atherosclerotic changes in aged rats with chronicrenal failure (CRF). Arch Gerontol Geriatr. 2008 Jan-Feb;46(1):25-39. Epub 2007Apr 6. PubMed PMID: 17418908. See more on PubMed
  • Krempl TK, Maas R, Sydow K, Meinertz T, Böger RH, Kähler J. Elevation ofasymmetric dimethylarginine in patients with unstable angina and recurrentcardiovascular events. Eur Heart J. 2005 Sep;26(18):1846-51. Epub 2005 Apr 28.PubMed PMID: 15860520. See more on PubMed
  • Melikian N, Wheatcroft SB, Ogah OS, Murphy C, Chowienczyk PJ, Wierzbicki AS,Sanders TA, Jiang B, Duncan ER, Shah AM, Kearney MT. Asymmetric dimethylarginine and reduced nitric oxide bioavailability in young Black African men.Hypertension. 2007 Apr;49(4):873-7. Epub 2007 Jan 29. PubMed PMID: 17261643. See more on PubMed
  • O'Dwyer MJ, Dempsey F, Crowley V, Kelleher DP, McManus R, Ryan T. Septic shockis correlated with asymmetrical dimethyl arginine levels, which may be influencedby a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: aprospective observational study. Crit Care. 2006;10(5):R139. PubMed PMID:17002794; PubMed Central PMCID: PMC1751072. See more on PubMed
  • Schnabel R, Blankenberg S, Lubos E, Lackner KJ, Rupprecht HJ, Espinola-KleinC, Jachmann N, Post F, Peetz D, Bickel C, Cambien F, Tiret L, Münzel T.Asymmetric dimethylarginine and the risk of cardiovascular events and death inpatients with coronary artery disease: results from the AtheroGene Study. CircRes. 2005 Sep 2;97(5):e53-9. Epub 2005 Aug 11. PubMed PMID: 16100045. See more on PubMed
  • Schulze F, Maas R, Freese R, Schwedhelm E, Silberhorn E, Böger RH.Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500subjects. Eur J Clin Invest. 2005 Oct;35(10):622-6. PubMed PMID: 16178881. See more on PubMed
  • Schulze F, Wesemann R, Schwedhelm E, Sydow K, Albsmeier J, Cooke JP, Böger RH.Determination of asymmetric dimethylarginine (ADMA) using a novel ELISA assay.Clin Chem Lab Med. 2004;42(12):1377-83. PubMed PMID: 15576299. See more on PubMed
  • Wanby P, Nilsson I, Brudin L, Nyhammar I, Gustafsson I, Carlsson M. Increased plasma levels of asymmetric dimethylarginine in patients with carotid stenosis:no evidence for the role of the common FABP2 A54T gene polymorphism. Acta Neurol Scand. 2007 Feb;115(2):90-6. PubMed PMID: 17212611. See more on PubMed
  • Wang TD, Chen WJ, Cheng WC, Lin JW, Chen MF, Lee YT. Relation of improvementin endothelium-dependent flow-mediated vasodilation after rosiglitazone tochanges in asymmetric dimethylarginine, endothelin-1, and C-reactive protein innondiabetic patients with the metabolic syndrome. Am J Cardiol. 2006 Oct15;98(8):1057-62. Epub 2006 Aug 28. PubMed PMID: 17027571. See more on PubMed
Summary References (9)

References to ADMA

  • Boger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res. 2003 Oct 1;59 (4):824-33
  • Lu TM, Ding YA, Lin SJ, Lee WS, Tai HC. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur Heart J. 2003 Nov;24 (21):1912-9
  • Nijveldt RJ, Teerlink T, Van Der Hoven B, Siroen MP, Kuik DJ, Rauwerda JA, van Leeuwen PA. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr. 2003 Feb;22 (1):23-30
  • Savvidou MD, Hingorani AD, Tsikas D, Frolich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet. 2003 May 3;361 (9368):1511-7
  • Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, Reaven GM, Tsao PS. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA. 2002 Mar 20;287 (11):1420-6
  • Testa A, Spoto B, Tripepi G, Mallamaci F, Malatino L, Fatuzzo P, Maas R, Boeger R, Zoccali C. The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease. J Hypertens. 2005 Oct;23 (10):1825-30
  • Testa A, Spoto B, Tripepi G, Mallamaci F, Malatino L, Fatuzzo P, Maas R, Boeger R, Zoccali C. The GLU298ASP variant of nitric oxide synthase interacts with asymmetric dimethyl arginine in determining cardiovascular mortality in patients with end-stage renal disease. J Hypertens. 2005 Oct;23 (10):1825-30
  • Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992 Mar 7;339 (8793):572-5
  • Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001 Dec 22-29;358 (9299):2113-7
Related Products Docs